Angle

finncap have advised ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company,on their fundraising of £18.0 million.

ANGLE Founder and Chief Executive, Andrew Newland, commented:

“We are grateful for the strong support of existing and new shareholders as we build our business to address the global liquid biopsy market. As well as strengthening the Company’s balance sheet in preparation for negotiating corporate partnerships, the proceeds from the Placing will allow us to establish a clinically approved service laboratory to drive business from pharmaceutical drug trials and accelerate use of the Parsortix system for treating patients.”